Understanding and managing patients with overlapping disorders of gut-brain interaction
- PMID: 36702144
- PMCID: PMC7615746
- DOI: 10.1016/S2468-1253(22)00435-6
Understanding and managing patients with overlapping disorders of gut-brain interaction
Abstract
Disorders of gut-brain interaction (DGBI) are frequently encountered in clinical practice, and recommendations for diagnosis and management are well established. In a large subset of patients, more than one DGBI diagnosis is present. This group of patients with more than one DGBI diagnosis have higher symptom severity and impact than patients with only one DGBI diagnosis, and the management approach is not well established for those with overlapping diagnoses. This Review aims to guide clinicians to understand, recognise, and manage overlapping DGBI by identifying causes and pitfalls of overlap conditions, and presenting potential practical approaches to diagnosis, treatment, and follow-up. Several clinical factors can contribute to finding overlapping DGBI, including the anatomical basis of the Rome diagnostic criteria, the potential confusion of symptom descriptors, and patients' biases towards higher symptom intensity ratings. Overlapping DGBI could also be caused by mechanistic factors such as pathophysiological mechanisms involving multiple gastrointestinal segments, and the effect of disorders in one segment on sensorimotor function in remote gastrointestinal parts, through neural or hormonal signalling. Key initial steps in the management of overlapping DGBI are detailed history taking, which can be facilitated using pictograms; carefully assessing the relative timing and cohesion of different symptoms; and recognising associated psychosocial dysfunction. Unnecessary technical investigations and complex combination treatment schedules should be avoided. Based on the identification of the dominant symptom pattern and putative underlying pathophysiological mechanisms, a single treatment modality should preferably be initiated, considering the efficacy spectrum of different therapies. Follow-up of the patient's condition allows the therapeutic approach to be adjusted as needed, while avoiding unnecessary additional technical investigations.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests JT has given scientific advice to Adare, AlfaWassermann, Arena, Bayer, Christian Hansen, Clasado, Danone, Devintec, Falk, FitForMe, Grünenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neurogastrx, Neutec, Novartis, Nutricia, Reckitt Benckiser, Ricordati, Shionogi, Takeda, Truvion, Tsumura, Zealand, and Zeria; has received research support from Biohit, Shire, Sofar, and Takeda; and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, FitForMe, Janssen, Kyowa Kirin, Mayoly, Menarini, Mylan, Novartis, Schwabe, Takeda, Wellspect, and Zeria. All other authors declare no competing interests.
Figures
Similar articles
-
Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.Nat Rev Gastroenterol Hepatol. 2025 Apr;22(4):228-251. doi: 10.1038/s41575-024-01033-9. Epub 2025 Jan 27. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39870943 Review.
-
A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome.Gut Microbes. 2024 Jan-Dec;16(1):2413367. doi: 10.1080/19490976.2024.2413367. Epub 2024 Oct 31. Gut Microbes. 2024. PMID: 39482844 Free PMC article. Review.
-
Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.Clin Gastroenterol Hepatol. 2022 May;20(5):e945-e956. doi: 10.1016/j.cgh.2021.05.042. Epub 2021 May 27. Clin Gastroenterol Hepatol. 2022. PMID: 34052391
-
Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population-based study.United European Gastroenterol J. 2024 Sep;12(7):834-847. doi: 10.1002/ueg2.12617. Epub 2024 Jul 8. United European Gastroenterol J. 2024. PMID: 38975964 Free PMC article.
-
Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.Gut Liver. 2024 Jul 15;18(4):578-592. doi: 10.5009/gnl230396. Epub 2024 Apr 29. Gut Liver. 2024. PMID: 38680110 Free PMC article. Review.
Cited by
-
Combined GWAS and single cell transcriptomics uncover the underlying genes and cell types in disorders of gut-brain interaction.medRxiv [Preprint]. 2023 Jun 5:2023.06.02.23290906. doi: 10.1101/2023.06.02.23290906. medRxiv. 2023. PMID: 37333423 Free PMC article. Preprint.
-
Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.Nat Rev Gastroenterol Hepatol. 2025 Apr;22(4):228-251. doi: 10.1038/s41575-024-01033-9. Epub 2025 Jan 27. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39870943 Review.
-
Overlapping disorders of gut-brain interaction -More may not be so merry!Indian J Gastroenterol. 2025 Aug;44(4):417-419. doi: 10.1007/s12664-025-01782-8. Indian J Gastroenterol. 2025. PMID: 40299239 No abstract available.
-
Comment on "Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center".Indian J Gastroenterol. 2025 Aug 5. doi: 10.1007/s12664-025-01844-x. Online ahead of print. Indian J Gastroenterol. 2025. PMID: 40762792 No abstract available.
-
Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study.Front Immunol. 2023 Oct 13;14:1267834. doi: 10.3389/fimmu.2023.1267834. eCollection 2023. Front Immunol. 2023. PMID: 37901213 Free PMC article.
References
-
- Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May;20(Suppl 1):121–9. - PubMed
-
- Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257–61. - PubMed
-
- Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, Fang X, Fukudo S, Ghoshal UC, Kellow J, Khatun R, et al. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life. Clin Gastroenterol Hepatol. 2022 May;20(5):e945–e956. - PubMed
-
- Holtmann GJ, Talley NJ. Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? Gut. 2018 Jun 19;:pii: gutjnl-2017-314775 - PubMed
-
- Siah KTH, Gong X, Yang XJ, Whitehead WE, Chen M, Hou X, Pratap N, Ghoshal UC, Syam AF, Abdullah M, Choi MG, et al. Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters. Gut. 2018 Jun;67(6):1071–1077. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources